SPH No. 1 Biochemical & Pharmaceutical Co., Ltd Sustainability Profile
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd., headquartered in China, is a prominent player in the biochemical and pharmaceutical industry. Established in [year founded], the company has made significant strides in research and development, focusing on innovative solutions for healthcare and life sciences. With a strong operational presence across major regions in Asia, SPH No. 1 is renowned for its core products, which include high-quality active pharmaceutical ingredients (APIs) and advanced biochemical formulations. These offerings are distinguished by their purity and efficacy, catering to a diverse range of therapeutic areas. Recognised for its commitment to quality and innovation, SPH No. 1 has achieved notable milestones, solidifying its market position as a trusted supplier in the pharmaceutical sector. The company continues to drive advancements in biochemistry, contributing to improved health outcomes globally.
DitchCarbon Score
How does SPH No. 1 Biochemical & Pharmaceutical Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd's score of 2 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd's reported carbon emissions
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd, headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd, which may influence its climate commitments and reporting practices. Despite the lack of direct emissions data, SPH No. 1 Biochemical & Pharmaceutical Co., Ltd is part of a corporate family that may have broader sustainability initiatives. However, there are no documented reduction targets or climate pledges available for this subsidiary. The absence of specific targets or achievements suggests that the company may still be in the early stages of developing its climate strategy. As the industry increasingly focuses on carbon neutrality and sustainability, it is essential for SPH No. 1 Biochemical & Pharmaceutical Co., Ltd to establish clear emissions reduction goals and commitments to align with global climate standards.
How Carbon Intensive is SPH No. 1 Biochemical & Pharmaceutical Co., Ltd's Industry?
How Carbon Intensive is SPH No. 1 Biochemical & Pharmaceutical Co., Ltd's Location?
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
